Yi Xu

Yi Xu

Auto-generated profile, based on publicly available information

Yi Xu

Department of Pharmacology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2024 in Cancer Discovery
Verified
Journal Article
Closed access
YXYi Xu
Yi Xu
XPXianlu Laura Peng
Xianlu Laura Peng
MEMichael P. East
Michael P. East
IMIan C. McCabe
Ian C. McCabe
GSGrace C. Stroman
Grace C. Stroman
JYJen Jen Yeh
Jen Jen Yeh
Effective therapies for pancreatic ductal adenocarcinoma (PDAC) have been largely elusive. In this study, we perform multiplexed kinase inhibitor bead mass spectrometry on 102 patient-derived xenografts derived from 14 unique primary PDACs to define the tumor-intrinsic kinome landscape. Our findings uncover three kinome subgroups making up two tumor-intrinsic kinome subtypes that we call kinotypes. The kinotypes show enrichment of different kinase classes and recapitulate previously described molecular subtypes, basal-like and classical. The kinotype characterizing basal-like tumors shows enrichment of receptor tyrosine kinases, whereas the kinotype characterizing classical tumors is enriched in understudied kinases involved in Wnt signaling and immune pathways. We validate our findings in two clinical trials and show that only patients with basal-like tumors derive significant benefit from EGFR inhibitors. Our results provide a comprehensive tumor-intrinsic kinome landscape of PDAC that strongly supports actionable kinotype-specific kinase targets and provides a roadmap for kinase inhibitor therapy in PDAC. Significance: We provide a comprehensive tumor-intrinsic kinome landscape that provides a roadmap for the use of kinase inhibitors in PDAC treatment approaches.

17 June 2026
Verified
Other
Open access
YXYi Xu
Yi Xu
XPXianlu Laura Peng
Xianlu Laura Peng
MEMichael P. East
Michael P. East
IMIan C. McCabe
Ian C. McCabe
GSGrace C. Stroman
Grace C. Stroman
JYJen Jen Yeh
Jen Jen Yeh
Supplementary Table 4.RASH_ACCEPT_stats

7 February 2025
Verified
Other
Open access
YXYi Xu
Yi Xu
XPXianlu Laura Peng
Xianlu Laura Peng
MEMichael P. East
Michael P. East
IMIan C. McCabe
Ian C. McCabe
GSGrace C. Stroman
Grace C. Stroman
JYJen Jen Yeh
Jen Jen Yeh
Supplementary Table 5.demographic_molecular_data

7 February 2025
Verified
Other
Open access
YXYi Xu
Yi Xu
XPXianlu Laura Peng
Xianlu Laura Peng
MEMichael P. East
Michael P. East
IMIan C. McCabe
Ian C. McCabe
GSGrace C. Stroman
Grace C. Stroman
JYJen Jen Yeh
Jen Jen Yeh
Supplementary Table 1.MIB_experimental_setup

17 June 2026
Verified
Other
Open access
YXYi Xu
Yi Xu
XPXianlu Laura Peng
Xianlu Laura Peng
MEMichael P. East
Michael P. East
IMIan C. McCabe
Ian C. McCabe
GSGrace C. Stroman
Grace C. Stroman
JYJen Jen Yeh
Jen Jen Yeh
Supplementary Table 5.demographic_molecular_data

7 February 2025
Verified
Other
Open access
YXYi Xu
Yi Xu
XPXianlu Laura Peng
Xianlu Laura Peng
MEMichael P. East
Michael P. East
IMIan C. McCabe
Ian C. McCabe
GSGrace C. Stroman
Grace C. Stroman
JYJen Jen Yeh
Jen Jen Yeh
Supplementary Table 3.ttest_basalclassical